Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Cancer stem cells: controversial or just misunderstood?

Jordan CT.

Cell Stem Cell. 2009 Mar 6;4(3):203-5. doi: 10.1016/j.stem.2009.02.003.

2.

The cancer stem cell gamble.

Kaiser J.

Science. 2015 Jan 16;347(6219):226-9. doi: 10.1126/science.347.6219.226. No abstract available.

3.

Targeting drug delivery systems for circumventing multidrug resistance of cancers.

Ju RJ, Mu LM, Lu WL.

Ther Deliv. 2013 Jun;4(6):667-71. doi: 10.4155/tde.13.39.

PMID:
23738665
4.

[Tumor stem cells and their impact on the concept of cancer treatment].

Lu SX.

Zhonghua Zhong Liu Za Zhi. 2010 Feb;32(2):81-3. Review. Chinese. No abstract available.

PMID:
20403234
5.

Cancer stem cells.

Yu Z, Pestell TG, Lisanti MP, Pestell RG.

Int J Biochem Cell Biol. 2012 Dec;44(12):2144-51. doi: 10.1016/j.biocel.2012.08.022. Epub 2012 Sep 2. Review.

6.

Cancer stem cells--important players in tumor therapy resistance.

Colak S, Medema JP.

FEBS J. 2014 Nov;281(21):4779-91. doi: 10.1111/febs.13023. Epub 2014 Sep 19. Review.

7.

Metastatic activity and chemotherapy resistance in human pancreatic cancer--influence of cancer stem cells.

Ischenko I, Seeliger H, Jauch KW, Bruns CJ.

Surgery. 2009 Sep;146(3):430-4. doi: 10.1016/j.surg.2009.05.003. Epub 2009 Jun 25. Review. No abstract available.

PMID:
19715799
8.

Is the cancer stem cell population "a player" in multi-drug resistance?

Drewa T, Styczynski J, Szczepanek J.

Acta Pol Pharm. 2008 Jul-Aug;65(4):493-500. Review.

9.

Targeting Cancer Stem Cells in Oral Cancer.

Xu Q, Le AD.

J Calif Dent Assoc. 2016 Feb;44(2):112-20. Review.

PMID:
26930754
10.

Concise review: Emerging concepts in clinical targeting of cancer stem cells.

Rasheed ZA, Kowalski J, Smith BD, Matsui W.

Stem Cells. 2011 Jun;29(6):883-7. doi: 10.1002/stem.648. Review.

11.

[Mechanisms of drug resistance and cancer stem cells].

Holčaková J, Nekulová M, Orzol P, Vojtěšek B.

Klin Onkol. 2014;27 Suppl 1:S34-41. Review. Czech.

PMID:
24945535
12.

Cancer stem cells: biological functions and therapeutically targeting.

Ciurea ME, Georgescu AM, Purcaru SO, Artene SA, Emami GH, Boldeanu MV, Tache DE, Dricu A.

Int J Mol Sci. 2014 May 9;15(5):8169-85. doi: 10.3390/ijms15058169. Review.

13.

ABCG2: the key to chemoresistance in cancer stem cells?

An Y, Ongkeko WM.

Expert Opin Drug Metab Toxicol. 2009 Dec;5(12):1529-42. doi: 10.1517/17425250903228834. Review.

PMID:
19708828
14.

The multiple facets of drug resistance: one history, different approaches.

Niero EL, Rocha-Sales B, Lauand C, Cortez BA, de Souza MM, Rezende-Teixeira P, Urabayashi MS, Martens AA, Neves JH, Machado-Santelli GM.

J Exp Clin Cancer Res. 2014 Apr 28;33:37. doi: 10.1186/1756-9966-33-37. Review.

15.

Cancer stem cells: an approach to identify newer therapeutic targets.

Srivastava S, Krishna S.

J Stem Cells. 2009;4(2):123-31. Review.

PMID:
20232597
16.

Cancer stem cells: are we missing the target?

Jones RJ, Matsui WH, Smith BD.

J Natl Cancer Inst. 2004 Apr 21;96(8):583-5. Review. No abstract available.

17.

Cancer stem cells in oncology.

Cetin I, Topcul M.

J BUON. 2012 Oct-Dec;17(4):644-8. Review.

PMID:
23335519
18.

Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance.

Easwaran H, Tsai HC, Baylin SB.

Mol Cell. 2014 Jun 5;54(5):716-27. doi: 10.1016/j.molcel.2014.05.015. Review.

19.

Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis.

Donnenberg VS, Donnenberg AD.

J Clin Pharmacol. 2005 Aug;45(8):872-7. Review.

PMID:
16027397
20.

Yin-yang balance therapy on regulating cancer stem cells.

Xu WR, Lin HS, Chen XY, Zhang Y.

J Tradit Chin Med. 2011 Jun;31(2):158-60.

Items per page

Supplemental Content

Write to the Help Desk